RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION
Lynch, J., Chun, DS., Berse, B., Venne, V., Efimova, O., DuVall, S., Filipski, KK., & Kelley, MJ. (2016). CLINICAL IMPACT OF THE 21-GENE RS TEST WITHIN THE VETERANS HEALTH CARE ADMINISTRATION. Value in Health, 19(3), A312-A312. https://doi.org/10.1016/j.jval.2016.03.2017
Appropriate use of of the 21-gene RS test decreased use of chemotherapy among low risk patients, and produced significant cost savings and potential improvements in health outcomes. Our study demonstrated opportunities to improve access to testing for eligible Veterans.